Kausik K. Ray
United Nations Industrial Development Organization(AT)Imperial College Healthcare NHS Trust(GB)Hammersmith Hospital(GB)LMU Klinikum(DE)Public Health England(GB)Institut d'Investigació Biomédica de Bellvitge(ES)Krishna Institute of Medical Sciences(IN)Stanford Health Care(US)NIHR Imperial Biomedical Research Centre(GB)Department of Health(ES)Baim Institute for Clinical Research(US)St Mary's Hospital(GB)Imperial Consultants(GB)European Atherosclerosis Society(SE)Instituto Biofisika(ES)Commonwealth Education Trust(GB)University Hospital Cologne(DE)CSIRO Manufacturing(AU)Karl Landsteiner Society(AT)GGG (France)(FR)Imperial College London(GB)Ludwig-Maximilians-Universität München(DE)University of Palermo(IT)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Health Systems, Economic Evaluations, Quality of Life, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Pharmaceutical Economics and Policy
Most-Cited Works
- → 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk(2019)8,575 cited
- → 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice(2021)5,933 cited
- → 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation(2020)4,917 cited
- → Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel(2017)3,675 cited
- → Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus(2013)3,444 cited
- → Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society